Dai Ichi Life Insurance Company, LTD Amgen Inc Transaction History

Dai Ichi Life Insurance Company, LTD

$3.9 Billion
Q3 2024

A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Amgen Inc stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 52,497 shares of AMGN stock, worth $14.6 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

52,497

Previous 55,538 5.48%

Holding current value

$14.6 Million

Previous $17.4 Million 2.52%

% of portfolio

0.43%

Previous 0.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $940,824 - $1.03 Million	-3,041 Reduced 5.48%	52,497 $16.9 Million
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $9.12 Million - $11.1 Million	-34,706 Reduced 38.46%	55,538 $17.4 Million
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $2.61 Million - $3.15 Million	-9,713 Reduced 9.72%	90,244 $25.7 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $7.42 Million - $8.37 Million	28,999 Added 40.87%	99,957 $28.8 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $3.61 Million - $4.48 Million	-16,516 Reduced 18.88%	70,958 $19.1 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $95,778 - $113,256	-447 Reduced 0.51%	87,474 $19.4 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.26 Million - $1.53 Million	5,569 Added 6.76%	87,921 $21.3 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $940,397 - $1.19 Million	-4,106 Reduced 4.75%	82,352 $21.6 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $678,093 - $764,766	-3,021 Reduced 3.38%	86,458 $19.5 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $5.19 Million - $5.77 Million	-22,479 Reduced 20.08%	89,479 $21.8 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $221,901 - $245,480	-1,012 Reduced 0.9%	111,958 $27.1 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $3.2 Million - $3.66 Million	-16,097 Reduced 12.47%	112,970 $25.4 Million
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $5.29 Million - $6.19 Million	-24,902 Reduced 16.17%	129,067 $27.4 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $4.65 Million - $5.16 Million	19,899 Added 14.84%	153,969 $37.5 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $997,707 - $1.16 Million	-4,496 Reduced 3.24%	134,070 $33.4 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $10.7 Million - $12.7 Million	49,451 Added 55.49%	138,566 $31.9 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $4.59 Million - $5.1 Million	19,552 Added 28.11%	89,115 $22.6 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $1.19 Million - $1.46 Million	6,009 Added 9.45%	69,563 $16.4 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $117,727 - $156,138	-646 Reduced 1.01%	63,554 $12.9 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $897,990 - $1.15 Million	4,746 Added 7.98%	64,200 $15.5 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $2.05 Million - $2.46 Million	-11,776 Reduced 16.53%	59,454 $11.5 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $7,001 - $8,207	-42 Reduced 0.06%	71,230 $13.1 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $116,299 - $131,094	-643 Reduced 0.89%	71,272 $13.5 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $1.28 Million - $1.49 Million	-7,178 Reduced 9.08%	71,915 $14 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $662,597 - $746,990	-3,576 Reduced 4.33%	79,093 $16.4 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $1.54 Million - $1.73 Million	-9,272 Reduced 10.08%	82,669 $15.3 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $114,195 - $133,452	-674 Reduced 0.73%	91,941 $15.7 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $468,223 - $523,148	-2,774 Reduced 2.91%	92,615 $16.1 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $16 Million - $18.2 Million	95,389	95,389 $17.8 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.

Account

Dai Ichi Life Insurance Company, LTD Amgen Inc Transaction History